Effect on Smoking Cessation of Switching Nicotine Replacement Therapy to Over-the-Counter Status
Anne N. Thorndike, MD, MPH,
Lois Biener, PhD and
Nancy A. Rigotti, MD
Anne N. Thorndike and Nancy A. Rigotti are with the General Medicine Division, Tobacco Research and Treatment Center, Medical Services, Massachusetts General Hospital and the Department of Medicine, Harvard Medical School, Boston, Mass. Lois Biener is with the Center for Survey Research, University of Massachusetts, Boston. Nancy A. Rigotti is also with the Institute for Health Policy, Massachusetts General Hospital/Partners HealthCare System, Inc, Boston, Mass.
Correspondence: Requests for reprints should be sent to Anne N. Thorndike, MD, MPH, Massachusetts General Hospital, General Medicine Unit, S50-9, Boston, MA 02114 (e-mail: athorndike{at}partners.org).
Objectives. This study examined whether the change in nicotinereplacement therapy sales from prescription to over the counter(OTC) status affected smoking cessation.
Methods. We used the 19931999 Massachusetts Tobacco Surveysto compare data from adult current smokers and recent quittersbefore and after the OTC switch.
Results. No significant change over time occurred in the proportionof smokers who used nicotine replacement therapy at a quit attemptin the past year (20.1% pre-OTC vs 21.4% post-OTC), made a quitattempt in the past year (48.1% vs 45.2%), or quit smoking inthe past year (8.1% vs 11.1%). Fewer non-Whites used nicotinereplacement therapy after the switch (20.7% pre-OTC vs 3.2%post-OTC, P = .002), but the proportion of Whites using nicotinereplacement therapy did not change significantly (20.6% vs 24.0%).
Conclusions. We observed no increase in Massachusetts smokers'rates of using nicotine replacement therapy, making a quit attempt,or stopping smoking after nicotine replacement therapy becameavailable for OTC sale. There appear to be other barriers tothe use of nicotine replacement therapy besides visiting a physician,especially among minority smokers. (Am J Public Health. 2002;92:437442)
This article has been cited by other articles:
N. Amodei and R. J. Lamb The role of nicotine replacement therapy in early quitting success
Nicotine Tob Res,
November 6, 2009;
(2009)
ntp164v1.
[Abstract][Full Text][PDF]
M. A. Wakefield, S. Durkin, M. J. Spittal, M. Siahpush, M. Scollo, J. A. Simpson, S. Chapman, V. White, and D. Hill Impact of Tobacco Control Policies and Mass Media Campaigns on Monthly Adult Smoking Prevalence
Am J Public Health,
August 1, 2008;
98(8):
1443 - 1450.
[Abstract][Full Text][PDF]
K. Messer, D. R. Trinidad, W. K. Al-Delaimy, and J. P. Pierce Smoking Cessation Rates in the United States: A Comparison of Young Adult and Older Smokers
Am J Public Health,
February 1, 2008;
98(2):
317 - 322.
[Abstract][Full Text][PDF]
D. E Levy, A. N Thorndike, L. Biener, and N. A Rigotti Use of nicotine replacement therapy to reduce or delay smoking but not to quit: prevalence and association with subsequent cessation efforts
Tob. Control,
December 1, 2007;
16(6):
384 - 389.
[Abstract][Full Text][PDF]
R. West and X. Zhou Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study
Thorax,
November 1, 2007;
62(11):
998 - 1002.
[Abstract][Full Text][PDF]
W K Al-Delaimy, E A Gilpin, and J P Pierce When California smokers use nicotine replacement therapy, most are trying to quit smoking
Tob. Control,
October 1, 2005;
14(5):
359 - 360.
[Full Text][PDF]
M. B. Reed, C. M. Anderson, J. W. Vaughn, and D. M. Burns The Effect of Over-the-Counter Sales of the Nicotine Patch and Nicotine Gum on Smoking Cessation in California
Cancer Epidemiol. Biomarkers Prev.,
September 1, 2005;
14(9):
2131 - 2136.
[Abstract][Full Text][PDF]
M. Franzon, G. Gustavsson, B. H. Korberly, D. O. Antonuccio, J. M. Cadore, L. F. Stead, R. M. Davis, M. C. Fiore, D. K. Hatsukami, M. Raw, et al. Effectiveness of Over-the-Counter Nicotine Replacement Therapy
JAMA,
December 25, 2002;
288(24):
3108 - 3110.
[Full Text][PDF]
C Miller, S Kriven, D Rowley, and L Abram Be wary of subsidising nicotine replacement therapy
Tob. Control,
December 1, 2002;
11(4):
380 - 381.
[Full Text]